Alexandra Freeman, MD
Gynecologic Oncology · Clovis, CANPI 1104168756
Payments from drug & device makers
What this record shows
Intuitive Surgical accounts for 63.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $893, more than ten times the $71 reported in 2019. That places this record below the midpoint for gynecologic oncology clinicians in CA, where the typical reported total is $1,602.
Across 26 payments — averaging $51.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$844
- AstraZeneca$266
- Johnson & Johnson$54
- Myriad Genetic Laboratories, Inc.$30
- Merck$27
- Caris MPI, Inc.$27
- plus $90 from 5 others
What the payments were for
- Food & beverage$57443%
- Education$76357%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $844 |
| AstraZeneca | 8 | $266 |
| Johnson & Johnson | 2 | $54 |
| Myriad Genetic Laboratories, Inc. | 1 | $30 |
| Merck | 2 | $27 |
| Caris MPI, Inc. | 1 | $27 |
| Fennec Pharmaceuticals, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Dysis Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$750
- LYNPARZA$131
How this compares
$1,338 in reported general payments places this provider in the 45th percentile of 152 gynecologic oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Clovis
- John ChanSan Francisco$2M
- Dana ChaseLos Angeles$1.3M
- Ramez EskanderEncinitas$706K
- Krishnansu TewariOrange$495K
- Fabio CappucciniOrange$313K
- Mehdi Moslemi-KebriaUpland$225K
- Amer KaramStanford$168K
- Rebecca BrooksSacramento$133K
- Kenneth KimWest Hollywood$88K
- Oliver DorigoStanford$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.